This Nu Holdings Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
Analysts downgraded NU, BAK, CLLS and CBZ; price targets for NU, BAK and CLLS were cut sharply.
Stocks · News reference
Crescent Capital BDC Q2 Adj. EPS $0.36 Misses $0.37 Estimate, Sales $36.323M Miss $37.316M Estimate
Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.37 by 2.7 percent. This is a 21.74 percent decrease over earnings of $0.46 per share
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Cellectis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded Banco Santander Brasil, Ribbon Communications, Cellectis, Scholar Rock, with mixed price-target changes.
This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded Chewy, Cooper Companies, AngloGold Ashanti and Crescent Capital BDC, cutting ratings and/or price targets.
B of A Securities Downgrades Crescent Capital BDC to Neutral, Lowers Price Target to $10.25
B of A Securities analyst Derek Hewett downgrades Crescent Capital BDC (NASDAQ:CCAP) from Buy to Neutral and lowers the price target from $13 to $10.25.